Several studies have linked the JAK/STAT pathway to amyloidosis and AD, and our molecular docking results showed that GS-Rd can interact directly with JAK2 and STAT3, suggesting that GS-Rd may exert anti-AD activity by regulating Aβ deposition through the modulation of the JAK/STAT pathway. This evidence concerns the gene SOAT1 and Alzheimer disease.